ERDERA at the Chan Zuckerberg Initiative workshop on systematically characterising rare diseases

ERDERA at the Chan Zuckerberg Initiative workshop on systematically characterising rare diseases

ERDERA coordination participated in the Chan Zuckerberg Initiative’s “Building a Roadmap to Systematically Characterize Rare Diseases” workshop, taking place March 24–26 at CZI Headquarters in Redwood City, California.  

This convening brought together leaders from across academia, industry, and patient advocacy to co‑create a strategic framework for defining essential parameters of rare disease characterisation, refining assays and technologies, mapping shared biological mechanisms, and developing an actionable pilot programme.  

ERDERA coordination was represented by Yanis Mimouni, ERDERA Assistant Coordinator, who contributed with the programmes perspective and expertise in fostering collaboration and driving progress towards scalable, cross‑organisation initiatives that advance and accelerate rare disease research. 

The workshop was organised by the Chan Zuckerberg Initiative (CZI), a philanthropic organisation founded by Mark Zuckerberg and Priscilla Chan dedicated to addressing some of society’s most significant challenges, including disease eradication, educational improvement, and meeting the needs of local communities. 

News & Updates

You might also be interested in

In its first year, ERDERA has brought together 10 000 harmonised genomic and phenotypic datasets from unsolved rare disease cases across Europe, creating a secure, standardised and scalable resource.
The European Medicines Agency has begun a formal review of Tavneos (avacopan) after emerging information raised questions about the integrity of key clinical trial data supporting its EU authorisation, with potential implications for adults living with rare autoimmune vasculitis.
Published on 14 December, this WHO technical document maps global trends in registered clinical studies using human genomic technologies from 1990 to 2024, including patterns of inclusion and equity.
Greater efforts are needed to invest in infrastructure, foster inclusive study designs and align research agendas.